CYpHER: Catalytic Extracellular TPD for Potent Durable Effect in Oncology & CNS Disease
Time: 9:00 am
day: Post-Conference Focus Day
Details:
- Engineering bispecific proteins that utilize transferrin receptor and pH-sensitive target binding to direct disease-driving proteins to the endolysosomal system
- Catalytic activity provides high potency and durability
- PD activity across mutational settings with superior activity and targeting versus traditional modalities
